The IMMUNE Building Standardhas been developed as a set of measures, technical solutions, and facility management practices to certify how built environments can withstand present and future health challenges and minimize the impact of a pandemic such as COVID-19 and other bacteriological or toxicological threats.
Early case reports and epidemiological studies of groups where SARS-CoV-2 has led to outbreaks of COVID-19 indicates that the primary means of disease transmission is the indoor spread of exhaled droplet aerosols.
The success of any filtration system depends upon its ability to capture the right contaminants in the right quantity whilst presenting the lowest resistance to the airflow.